Company Research Report: Clarivate™

Company Overview

Name

Clarivate™

Mission of the Company

Clarivate is committed to connecting people and organizations to the intelligence they can trust to transform their perspective, their work, and the world. Their aim is to fuel the world’s greatest breakthroughs by harnessing the power of human ingenuity.

Founding Details

Founded: 1864

Original Foundation: Zoological Record; world's oldest continuing database of animal biology.

Evolution: Over the years, Clarivate has expanded its range to include data, insights, analytics, and workflow solutions.

Key People

Bill Graff: Chief Information Officer

Matti Shem Tov: Appointed as CEO (as of August 2024)

Jonathan Gear: Former CEO transitioning to non-executive role

Andy Snyder: Chairman of the Clarivate Board

Headquarters

Clarivate™ is headquartered in London, U.K.

Number of Employees

Clarivate has more than 11,000 employees globally.

Revenue

No information is available.

Notable Achievements

Known as a leading global provider of transformative intelligence, Clarivate offers services in areas such as Academia & Government, Intellectual Property, and Life Sciences & Healthcare. They have a strong presence with a network of over 45,000 customers worldwide.

Products

Product Families

CompuMark

Cortellis

Darts-ip

Derwent

Dialog

Drug Safety Triager

Ex Libris

Healthcare Business Insights

Innovative

ProQuest

Web of Science

Product Descriptions and Key Features

1. Cortellis: Provides comprehensive R&D insights and predictive compound safety and efficacy insights, contributing to drug discovery and development.
2. ProQuest: Delivers enriched data, insights, and analytics for academia and government, part of their acquisition leading to leadership by notable industry experts.
3. Web of Science: Offers a reliable citation database for scientific and academic research, identifying influential research and its impact on various disciplines.
4. OFF-X™: A new platform offering translational safety intelligence, providing data on drug and target safety, aiding in risk mitigation.

Recent Developments

Recent Developments in the Company

1. Leadership Changes: Matti Shem Tov was appointed as the new CEO in August 2024.
2. Acquisition: Acquired Rowan TELS Corp to enhance support for patent practitioners with patent drafting and prosecution solutions.
3. Technological Advancements: Launched OFF-X™ platform and expanded capabilities with integrated safety intelligence and predictive analytics.

New Products Launched

1. OFF-X™ Platform: Enhances preclinical and clinical safety intelligence.
2. VeriSIM Life Translational Index™: Integrated on Cortellis Drug Discovery to provide advanced AI-enabled predictive analytics for drug development.

New Features Added

Enhanced technology stack within the OFF-X™ platform, includes improved data visualization and analytics tools for faster and more comprehensive data access.

New Partnerships

VeriSIM Life Partnership: To expand AI-enabled occupational predictive analytics in drug development.

Partnerships in IP Management: Clarivate announced collaborations aimed at transforming medtech sales and optimizing strategic IP assets in partnerships with companies like TerraSky.

This report is curated strictly based on the information provided and available. Invisible sections from the prompt reflect areas where no data could be extracted or provided. For further information, please contact Clarivate directly or access their publicly available resources and filings.